An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy
Clinical trial NCT06288230 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06288230
- Sponsor
- Lantu Biopharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-20
- Primary completion
- 2027-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.